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Abstract. A total of 6 newly-synthesized styrylchromones 
(SC-1~SC-6) were compared for their cytotoxic activity against
three normal oral human cells (gingival fibroblast HGF, pulp cell
HPC, periodontal ligament fibroblast HPLF) and four human
tumor cell lines (squamous cell carcinoma HSC-2, HSC-3,
submandibular gland carcinoma HSG, promyelocytic leukemia
HL-60). All compounds showed higher cytotoxic activity against
tumor cell lines than against normal cells. Among the 6
compounds, SC-3, SC-4 and SC-5, which have one to three
methoxy groups, showed higher tumor specificity and water
solubility. The cytotoxic activity of SC-3 and SC-5 was slightly
reduced by a lower concentration of NADH, a quinone reductase,
but that of SC-3 was enhanced by higher concentrations of
NADH, possibly due to demethylation of the methoxy groups.
Agarose gel electrophoresis demonstrated that SC-3 and SC-5
induced internucleosomal DNA fragmentation in HL-60 cells and
production of large DNA fragment in HSC-2 cells. Both SC-3 and
SC-5 enhanced the enzymatic activity to cleave the substrates for
caspases 3, 8 and 9, suggesting the activation of both extrinsic and
intrinsic apoptosis pathways. ESR spectroscopy showed that these
compounds produced no detectable amount of radical and did
not scavenge superoxide anion generated by the hypoxanthine-
xanthine oxidase reaction. The highly tumor-specific cytotoxic
action and apoptosis-inducing capability of SC-3 and SC-5
suggest their applicability for cancer chemotherapy.
We have screened a variety of natural and synthetic
materials which can effectively and selectively kill human
oral tumor cell lines. Among natural substances, lignins
showed very low cytotoxic activity, but synergistically
stimulated the cytotoxic action of vitamins C (1) and K (2).
Macrocyclic hydrolysable tannins (3) and isoprenylated
flavones (4, 5) effectively induced apoptotic cell death (DNA
fragmentation, caspase activation) in oral tumor cell lines. 
Synthetic compounds, such as benzothiepins,
benzoxepins, 5-benzoylimidazoles (6-8) and 2-amino-
methylene-3(2H)-benzofuranones (9) showed higher
cytotoxic activity against human oral tumor cell lines
(squamous cell carcinoma HSC-2, HSC-3, submandibular
gland carcinoma HSG) than against human normal 
cells (gingival fibroblast HGF), suggesting the tumor-
specific cytotoxic action of these compounds. Among 
2-styrylchromone derivatives, hormothamnione showed
cytotoxicity toward P388 mouse leukemic and HL-60 human
promyelocytic leukemic cell lines via inhibition of RNA
synthesis (10). Oral administration of several compounds,
all substituted at C-6 with a carboxylic acid group, showed
anti-allergic activity (11). Synthetic 2-styrylchromone
derivatives, with carboxylate substitution at C-6, and styryl-
chromone-8-acetic acid derivatives showed anticancer
activity (12). These data suggest the possible application of
styrylchromone derivatives as anticancer drugs. We newly
synthesized a total of 6 styrylchromones (Figure 1) (13, 14).
We investigated here whether they display tumor-specific
cytotoxic action, using three normal oral human cells (HGF,
pulp cell HPC, human periodontal ligament fibroblast
HPLF) and four human tumor cell lines (HSC-2, HSC-3,
HSG, HL-60) and, if so, whether they can induce apoptosis-
associated characteristics such as internucleosomal DNA
fragmentation and caspase activation in the tumor cell lines.
We also investigated whether radical-mediated reactions are
involved in the induction of cytotoxicity, using ESR
spectroscopy.
157
*Summer-time student of Faculty of Pharmaceutical Sciences,
Josai University
Correspondence to: Hiroshi Sakagami, Department of Dental
Pharmacology, Meikai University School of Dentistry, Sakado,
Saitama 350-0283, Japan. Tel:(+81)49-279-2758, 2759, Fax:(+81)49-
285-5171, e-mail: sakagami@dent.meikai.ac.jp
Key Words: Styrylchromones, cytotoxic activity, oral tumor cells,
tumor specificity, DNA fragmentation, caspase.
in vivo 19: 157-164 (2005)
Cytotoxic Activity of Styrylchromones 
against Human Tumor Cell Lines
KANAE MOMOI1*, YOSHIAKI SUGITA1, MARIKO ISHIHARA2, KAZUE SATOH3, 
HIROTAKA KIKUCHI4, KEN HASHIMOTO3, ICHIRO YOKOE1, 
HIROFUMI NISHIKAWA4, SEIICHIRO FUJISAWA5 and HIROSHI SAKAGAMI3
1Faculty of Pharmaceutical Sciences, Josai University, Sakado, Saitama 350-0295; 
Departments of 2Chemistry, 3Dental Pharmacology, 4Endodontics and
5Oral Diagnosis, Meikai University School of Dentistry, Sakado, Saitama 350-0283, Japan
0258-851X/2005 $2.00+.40
Materials and Methods
Materials. The following reagents were obtained from the indicated
companies: Dulbecco’s modified Eagle medium (DMEM),
RPMI1640 medium (Gibco BRL, Grand Island, NY, USA); fetal
bovine serum (FBS) (JRH Biosci, Lenexa, KS, USA); dimethyl
sulfoxide (DMSO) (Wako Pure Chem, Ind, Ltd, Osaka, Japan); 3-
[4,5-dimetylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT),
hypoxanthine (HX), xanthine oxidase (XOD) (Sigma Chem. Ind.,
St. Louis, MO, USA); RNase A, proteinase K (Boehringer
Mannheim, Germany); DEVD-pNA (p-nitroanilide), IETD-pNA,
LEHD-pNA (MBL, Nagoya, Japan); diethylenetriaminepentaacetic
acid (DETAPAC) (Wako Pure Chem, Ind, Ltd); 5,5-dimethyl-1-
pyrroline-N-oxide (DMPO), superoxide dismutase (SOD) from
bovine erythrocytes (Dojin, Kumamoto, Japan).
General procedure for the synthesis of 2-styrylchromones (SC-1~6).
To a solution of Na (0.46 g, 0.02 mol) in 10 mL of EtOH was
added 1.6 g of 2-methylchromone (0.01 mol) and 0.012 mol of
aromatic aldehyde. The solution was left to stand at room
temperature for 12 hours, then poured into ice-water and filtered
to obtain the precipitate, which was washed with water and
recrystallized from MeOH to give 2-styrylchromones (SC-1~6)
(Figure 1).
Cell culture. All adherent cells [HSC-2, HSC-3, HSG (purchased
from Japanese Collection of Research Bioresources (JCRB) Cell
Bank), HGF, HPC, HPLF] were cultured in DMEM medium
supplemented with 10% heat-inactivated FBS in a humidified 5%
CO2 atmosphere. Normal cells (HGF, HPC, HPLF) were prepared
from the periodontal tissue, according to the guideline of the
Meikai University Ethics Committee (No. 0206). Since normal
human cells have a limited in vitro life-span (15), these cells were
used in the present study at 6-7 population doubling level (PDL).
HL-60 cells were cultured in RPMI 1640 medium supplemented
with 10% FBS. 
Assay for cytotoxic activity. Near confluent cells grown in 96-
microwell plate (Falcon, flat bottom, treated polystyrene, Becton
Dickinson) were incubated for 24 hours with various concentrations
of samples. The cells were washed once with phosphate-buffered
saline (PBS), and incubated for a further 4 hours with fresh culture
medium containing 0.2 mg/mL MTT. After removing the medium,
the cells were lysed with 100 ÌL DMSO and the relative viable cell
number was determined by measuring the absorbance at 540 nm of
the cell lysate, using microplate reader with a Star/DOT Matrix
Printer JL-10 (Labsystem Multiskan®, Biochromatic, Helsinki,
Finland). Viable cell number of HL-60 cells was determined by
trypan blue exclusion. The 50% cytotoxic concentration (CC50) was
determined from the dose-response curve.
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Figure 1. Structures of styrylchromones. 
Detection of morphological changes. Cells were prepared on slides
by use of Shandon Cytospin II (Baltimore, Maryland, USA), and
they were stained by May-Gruenwald’s solution and Giemsa
solution (30 min) (16).
Assay for DNA fragmentation. The cells were pelleted, lysed and
digested with RNase A and proteinase K. DNA was isolated and
assayed for DNA fragmentation by 2% agarose gel electrophoresis.
The DNA isolated from the UV-irradiated HL-60 cells was run in
parallel, as a marker of oligonucleosomal DNA fragments (17).
Assay for caspase activation. Cells were washed with PBS and lysed
in lysis solution (MBL, Nagoya). After standing for 10 minutes on
ice and centrifugation for 5 minutes at 10,000 xg, the supernatant
was collected. Lysate (50 ÌL, equivalent to 200 Ìg protein) was
mixed with 50 ÌL 2x reaction buffer (MBL) containing substrates
for caspase 3 (DEVD-pNA (p-nitroanilide)), caspase 8 (IETD-
pNA) or caspase 9 (LEHD-pNA). After incubation for 2 hours at
37ÆC, the absorbance at 405 nm of the liberated chromophore pNA
was measured by microplate reader.
Assay for radical intensity. The radical intensity of the test sample in
0.1 M NaCO3/NaHCO3 buffer (pH 10.0) or in 0.1 M KOH (pH
12.5) was determined at 25ÆC, using ESR spectroscopy (JEOL JES
REIX, X-band, 100 kHz modulation frequency). Instrument
settings; center field, 336.0±5.0 mT; microwave power, 8 mW;
modulation amplitude, 0.1 mT: gain, 500 or 630, time constant, 0.03
or 0.1 second; scanning time, 2 or 4 minutes .
For determination of superoxide anion radical (O2-) produced by
hypoxanthine (HX) and xanthine oxidase (XOD) reaction (total
volume: 200 ÌL) [2 mM HX in 0.1 M phosphate buffer (pH 7.4)
(PB) 50 ÌL, 0.5 mM DETAPAC 20 ÌL, 50% DMPO 10 ÌL, 0.1 M
PB 20 ÌL, sample (in DMSO) 50 ÌL, XOD (0.5 U/ml in PB) 50 ÌL],
the gain, time constant and scanning time were changed to 500, 0.1
second and 2 minutes, respectively. The radical intensity was
determined by ESR spectroscopy 1 minute after mixing (18).
Computational details. Theoretical calculations were carried out,
using the restricted Hartree-Fock level (HPL) PM3 semi-empirical
method, as implemented in the MOPAC program on a Tektronix
CAChe work system (version 3.8). Log P was calculated, using a
relative permittivity of 78.4 for water for the COSMO model.
Giometries were optimized in internal coordinates and were
terminated when the Herberts test was satisfied in the eigenvector
following method (EP) (19, 20).
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Table I. Cytotoxic activity of styrylchromones.
CC50 (ÌM)
Tumor cell lines Normal cells
HSC-2 HSC-3 HSG HL-60 HGF HPC HPLF SI a)
(Exp. I)
SC-1 460 198 315 129 669 1097 504 2.8
SC-2 263 233 1294 115 1431 2767 527 3.3
SC-3 133 43 101 50 1665 899 835 13.8
SC-4 393 97 393 62 750 2721 2318 8.2
SC-5 92 41 30 163 2207 2243 2219 27.3
SC-6 599 >3425 1784 >3425 1198 2377 2086 <0.8
(Exp. II)
SC-1 367 476 427 706 819 657 1.7
SC-2 214 649 847 >3817 1702 2057 >4.4
SC-3 317 191 86 1198 2331 2421 10.0
SC-4 2244 282 331 295 >3247 2588 >2.1
SC-5 59 278 139 1787 317 1479 7.5
SC-6 216 3253 2620 >3425 3051 1904 1.4
a) Selectivity index (SI) of tumor specificity was defined by the following equation. 
(Exp I.)
CC50 (HGF)+CC50 (HPC)+CC50 (HPLF)  4
SI= x 
CC50 (HSC-2)+CC50 (HSC-3)+CC50 (HSG)+CC50 (HL-60) 3
(Exp. II)
CC50 (HGF)+CC50 (HPC) +CC50 (HPLF)
SI=
CC50 (HSC-2)+CC50 (HSC-3)+CC50 (HSG) 
Results
Tumor-specific action. All six compounds (SC-1~SC-6)
showed higher cytotoxicity against tumor cell lines as
compared with normal cells (Table I). The tumor-specific
cytotoxicity of these compounds was evaluated by selectivity
index (SI). SC-3, SC-4 and SC-5, particularly SC-3 and SC-5,
showed much higher tumor-specific cytotoxic activity [SC-3
(SI=10.0-13.8), SC-4 (SI=2.1-8.2), SC-5 (7.5-27.3)] than the
other compounds [SC-1 (SI=1.7-2.8), SC-2 (SI=3.3-4.4), SC-6
(SI=0.8-1.4)]. The compounds with methoxy groups (SC-3,
4, 5) showed greater tumor-specific cytotoxicity, despite
higher water solubility (lower log P value) (Figure 2). 
The cytotoxic activity of SC-3 and SC-5 was slightly
reduced by a lower concentration of NADH (0.05-0.5 mM),
but that of SC-3 was enhanced by higher concentrations of
NADH (5 mM) (Figure 3).
Induction of apoptosis. Agarose gel electrophoresis showed
that SC-3 and SC-5 induced internucleosomal DNA
fragmentation (Figure 4A) and production of apoptotic
bodies (data not shown) in HL-60 cells. The DNA
fragmentation was more pronounced at 24 hours than at 6
hours (Figure 4A). On the other hand, SC-3 and SC-5
induced the production of large DNA fragments without
induction of internucleosomal DNA fragmentation in HSC-2
cells (arrows in Figure 4B). 
We next investigated whether these compounds activate
three representative caspases (caspases 3, 8, 9), monitoring
the ability of cell lysate to cleave the substrates for them.
Figure 5 shows that both SC-3 and SC-5 actually activated
caspases 3, 8 and 9. The activation of caspases by SC-3
exceeded that achieved by UV irradiation (positive
control) (17). 
Radical production. ESR spectroscopy showed that all six
styrylchromones (SC1-6) produced no detectable amount of
radical under alkaline condition (pH 10, 12.5) (Figure 6A)
and did not scavenge superoxide anion generated by the
hypoxanthine-xanthine oxidase reaction (Figure 6B).
Discussion
The present study demonstrates that all 6 newly-synthesized
styrylchromones (SC-1~SC-6) showed various extents of
tumor-specific cytotoxicity. Among these compounds, SC-3
and SC-5 showed the highest tumor specificity, followed by
SC-4. Since these compounds have one to three methoxy
group(s), these methoxy groups may be involved in the
induction of tumor-specific cytotoxicity. 2-Styrylchromones
have recently been identified as antirhinovirus flavonoids.
The introduction of a hydroxy or methoxy group in position
3 of the chromone ring enhances the cytotoxicity and
antiviral activity (21). Conversely, the cytotoxic activity of
flavonoids with a styrylchromone structure against tumor
cells is not produced by the lack of a methoxy group (22).
In sytylchromone-related compounds, the methoxy groups
in vivo 19: 157-164 (2005)
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Figure 2. Relationship between tumor specificity and log P.
Figure 3. Effect of NADH on the cytotoxic activity of SC-3 and SC-5.
Near confluent HSC-2 cells were incubated for 24 hours with the indicated
concentrations of SC-3 or SC-5 in the presence of 0 (●), 0.05 (■), 0.5
(▲) or 5 mM (◆) NADH, and the relative viable cell number was then
determined by MTT method. Control A540 value was 0.998 (for SC-3) and
0.873 (for SC-5), respectively.
may be essential for the induction of cytotoxicity and
apoptosis. The enzymatic mechanism involving oxidation to
the ortho-quinone has been previously reported in
methoxyphenols where the methoxy group is demethylated
(23). We found that the cytotoxicity of SC-3 was
significantly enhanced by the addition of a higher
concentration (5 mM) of NADH, but reduced by lower
concentrations of NADH. The cytotoxicity and apoptosis-
inducing activity of butylated hydroxytoluene (BHT) was
significantly enhanced by NADH, possibly due to the
reduction of BHT intermediates to cytotoxic semiquinone
in the cells (24). The present study strongly suggests that the
addition of NADH stimulates the formation of
orthoquinone in styrylchromones (SC-4, SC-5) and quinone
in SC-3 by demethylating the methoxy groups enzymatically,
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Figure 5. Activation of caspases by SC-3 and SC-5 in HL-60 cells. HL-60
cells were incubated for 4 hours with 100 Ìg/mL of SC-3 or SC-5 and caspase
activity was determined by cleavage of respective substrates. UV, positive
control of apoptotic cells induced by UV irradiation (6J/m2/min, 1 min) (17).
Figure 4. Induction of internucleosomal DNA fragmentation by SC-3 and SC-5. Near confluent HL-60 (A) and HSC-2 (B) cells were incubated for 6
or 24 hours with the indicated concentrations of SC-3 or SC-5. DNA was then extracted and applied to agarose gel electrophoresis. 
even though styrylchromones were not oxidized under
alkaline conditions.
SC-3 and SC-5 induced apoptosis characterized by
internucleosomal DNA fragmentation and caspase 3
activation. Since these compounds activated both the non-
mitochondrial extrinsic pathway (involved with caspase 8)
and the mitochondrial intrinsic pathway (involved with
caspase 9) (25), they may induce the activation of caspase 3
by both of these pathways and finally activate the DNase,
which induces internucleosomal DNA fragmentation (26,
27). Our recent study demonstrated that apoptosis-inducing
agents do not always show tumor-specific cytotoxicity and
that compounds with higher tumor-specific cytotoxicity do
not always induce apoptosis (manuscript in preparation). In
this sense, SC-3 and SC-5, which show both tumor-
specificity and apoptosis-inducing activity, are very
promising for future application to cancer research. This
may be related to the formation of cytotoxic orthoquinone
due to enzymatical demethylation of methoxy groups. In
contrast, SC-6 did not show any tumor-specificity,
suggesting that substituents of OCH2O were not
dehydrolized due to ether bonding and, consequently, did
not form cytotoxic orthoquinone. We found that fibroblasts
from oral origin were less sensitive to styrylchromones.
Fibroblastoid cells exhibit high resistance to quinone
compounds because of the high activity of quinone
reductase (28). The clinical value of compounds with lower
tumor-specificity may be low, even though they can induce
apoptosis in certain types of tumor cell lines. 
SC-3 and SC-5 induced internucleosomal DNA
fragmentation only in HL-60 cells, but not in HSC-2 cells,
although these cell lines are relatively sensitive to many
apoptosis-inducing agents. This suggests that induction of
either internucleosomal DNA fragmentation or production
of large DNA fragments may depend on the cell types
rather than drug sensitivity. 
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Figure 6. Radical intensity and O2- scavenging activity of styrylchromones. (A) Sample (final: 2 mg/mL) was added. (B) Sample (final: 2 mg/mL) was added.
We suggest that SC3 and SC5 should further be tested as
possible candidates for cancer chemotherapy. 
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